start portlet menu bar end portlet menu bar

RHINISENG®: Field safety

Home Knowledge RHINISENG®: Field safety

RHINISENG®: Field safety

RHINISENG® is a vaccine against progressive (PAR) and nonprogressive atrophic rhinitis (NPAR) indicated for pregnant sows and gilts to passively protect their offspring. The RHINISENG® recommended vaccination scheme includes a basic vaccination scheme (vaccination 8-6 weeks before farrowing and revaccination 4-3 weeks before farrowing) and a booster dose (4-3 weeks before the subsequent farrowing). This study evaluated the vaccine field safety of the basic vaccination scheme and the booster dose.

Download this article

1.01 MB

About this article

Authors

Noguera, M.; Montané, J.; Monells, M.; Ruíz, M. C.; Roca, M.; Camprodon, A.; Sitjà, M.; March, R.

Summary

No systemic or abnormal local reactions were observed. Both, the basic vaccination scheme and the booster scheme had no effects on the reproductive performance of sows. No abortions were observed over the study period or teratogenic effects on the progeny. No differences were observed in the liveborn piglet, stillborn piglet and mummified foetus average between control and vaccinated sows (Table 1). RHINISENG® demonstrated an optimal safety under field conditions in pregnant sows and gilts.

Related services

HIPRA Diagnos

Related products

RHINISENG®

Related publications

The use of oral fluid from pigs for the diagnosis of atrophic rhinitis RHINISENG®: Field efficacy RHINISENG®: Efficacy of the basic vaccination scheme (vaccination and revaccination) and the booster vaccination

Share this on

start portlet menu bar end portlet menu bar

See also

Publications

Safety comparative study of two reproductive vaccines administered during lactation

06-03-2018
Disease Summaries

Edema disease

03-11-2017
News

HIPRA begins its journey into Taiwan with the SENG range

06-04-2018